Related references
Note: Only part of the references are listed.A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma
Steven C. Kao et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop
Ling Chen et al.
CANCER RESEARCH (2015)
Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma
Wei Kang et al.
MOLECULAR CANCER (2015)
The miR-15 Family Enhances the Radiosensitivity of Breast Cancer Cells by Targeting G2 Checkpoints
Zijie Mei et al.
RADIATION RESEARCH (2015)
Growth factor receptor/steroid receptor cross talk in trastuzumab-treated breast cancer
D. C. Collins et al.
ONCOGENE (2015)
Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance
R. I. Cordo Russo et al.
ONCOGENE (2015)
MicroRNAome Genome: A Treasure for Cancer Diagnosis and Therapy
Ioana Berindan-Neagoe et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Carlos L. Arteaga et al.
CANCER CELL (2014)
A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond
Carlos Gomez-Martin et al.
CANCER LETTERS (2014)
MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor- κB1/MMP9 signaling pathway
Tian-Quan Yang et al.
CANCER SCIENCE (2014)
HER2 aberrations in cancer: Implications for therapy
Min Yan et al.
CANCER TREATMENT REVIEWS (2014)
A microRNA 221-and 222-Mediated Feedback Loop Maintains Constitutive Activation of NFκB and STAT3 in Colorectal Cancer Cells
Sanhong Liu et al.
GASTROENTEROLOGY (2014)
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
Nobuhiro Okada et al.
GENES & DEVELOPMENT (2014)
Regulation of Human Growth Hormone Receptor Expression by MicroRNAs
Samar Elzein et al.
MOLECULAR ENDOCRINOLOGY (2014)
Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer
Emil Stajduhar et al.
TUMOR BIOLOGY (2014)
Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA study
Andreas Schneeweiss et al.
BREAST CANCER RESEARCH (2014)
MicroRNA-16 Inhibits Bladder Cancer Proliferation by Targeting Cyclin D1
Qi-Quan Jiang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/Neu, EGF, and TNF-α in Breast Cancer
Lianjin Jin et al.
CANCER RESEARCH (2013)
MEK Inhibition Increases Lapatinib Sensitivity Via Modulation of FOXM1
S. S. Gayle et al.
CURRENT MEDICINAL CHEMISTRY (2013)
miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma
Lei Chen et al.
FEBS LETTERS (2013)
Far upstream element binding protein 1: a commander of transcription, translation and beyond
J. Zhang et al.
ONCOGENE (2013)
miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-α, CCNJ, and MEGF9
Andrea Feliciano et al.
PLOS ONE (2013)
Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
Poornima Bhat-Nakshatri et al.
SCIENTIFIC REPORTS (2013)
Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line
Yong Yook Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Multiple microRNAs induced by Cdx1 suppress Cdx2 in human colorectal tumour cells
Takanobu Tagawa et al.
BIOCHEMICAL JOURNAL (2012)
Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells
Xinfeng Yu et al.
BMC CANCER (2012)
miRNA-34a is associated with docetaxel resistance in human breast cancer cells
L. Kastl et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo
Lixia Dai et al.
CELL BIOLOGY INTERNATIONAL (2012)
Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas
X. Zhang et al.
ONCOGENE (2012)
MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors
Long R. Jiao et al.
PLOS ONE (2012)
Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells
Takehiro Ichikawa et al.
PLOS ONE (2012)
Modulation of MicroRNA-194 and Cell Migration by HER2-Targeting Trastuzumab in Breast Cancer
Xiao-Feng Le et al.
PLOS ONE (2012)
Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells
Noelia Agra Andrieu et al.
PLOS ONE (2012)
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
Martin A. Rivas et al.
BREAST CANCER RESEARCH (2012)
MicroRNA-16 and MicroRNA-424 Regulate Cell-Autonomous Angiogenic Functions in Endothelial Cells via Targeting Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1
Aranzazu Chamorro-Jorganes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
Giorgio Valabrega et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
MicroRNA-125a-5p Is an Independent Prognostic Factor in Gastric Cancer and Inhibits the Proliferation of Human Gastric Cancer Cells in Combination with Trastuzumab
Naohiro Nishida et al.
CLINICAL CANCER RESEARCH (2011)
HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells
Wei Bao et al.
GASTROENTEROLOGY (2011)
Differential Regulation of N-Myc and c-Myc Synthesis, Degradation, and Transcriptional Activity by the Ras/Mitogen-activated Protein Kinase Pathway
Katannya Kapeli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
Espen Enerly et al.
PLOS ONE (2011)
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients
Maurizio Scaltriti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
Joan T. Garrett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Transactivation of ErbB-2 induced by tumor necrosis factor α promotes NF-κB activation and breast cancer cell proliferation
Martin A. Rivas et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells
Katri Koninki et al.
CANCER LETTERS (2010)
Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
Guanglei Zhuang et al.
CANCER RESEARCH (2010)
Oncogenic HER2δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
Diana M. Cittelly et al.
CARCINOGENESIS (2010)
Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib
Neil A. O'Brien et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Molecular predictors of response to trastuzumab and lapatinib in breast cancer
Francisco J. Esteva et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
Resham Bhattacharya et al.
CANCER RESEARCH (2009)
miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non-Small Cell Lung Cancer
Nora Bandi et al.
CANCER RESEARCH (2009)
Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab
Evelyn Yao et al.
CLINICAL CANCER RESEARCH (2009)
Up-regulation of miR-21 by HER2/neu Signaling Promotes Cell Invasion
Tzu-Hsuan Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Neil L. Spector et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
miRecords: an integrated resource for microRNA-target interactions
Feifei Xiao et al.
NUCLEIC ACIDS RESEARCH (2009)
Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene
M. Jang et al.
ONCOGENE (2009)
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
Jeffrey S. Ross et al.
ONCOLOGIST (2009)
Expression of t-DARPP mediates trastuzumab resistance in breast cancer cells
Abbes Belkhiri et al.
CLINICAL CANCER RESEARCH (2008)
Brk is coamplified with ErbB2 to promote proliferation in breast cancer
Bin Xiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Widespread microRNA repression by Myc contributes to tumorigenesis
Tsung-Cheng Chang et al.
NATURE GENETICS (2008)
Determinants of RNA Quality from FFPE Samples
Silke von Ahlfen et al.
PLOS ONE (2007)
Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB Ligands and remain dependent on the ErbB receptor network
Christoph A. Ritter et al.
CLINICAL CANCER RESEARCH (2007)
Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer
Maurizio Scaltriti et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Involvement of MicroRNA in AU-rich element-mediated mRNA instability
Q Jing et al.
CELL (2005)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Post-transcriptional control of c-erb B-2 overexpression in stomach cancer cells
CD Bae et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2001)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression
LS He et al.
EMBO JOURNAL (2000)
Share Paper
